Colorectal Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2006; 12(43): 6961-6965
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6961
Table 1 Prognostic factors entered into multivariate analysis based on proposed clinical and histopathological features
VariablePatients (n)
Gender (male/female)61/20
Age at hepatectomy (< 60/≥ 60)32/49
Chronology of hepatic metastasis (synchronous/metachronous)41/40
Disease free interval after colectomy ( ≤ 1 yr/> 1 yr)56/25
Extrahepatic distant metastases (no/yes)72/9
CEA ( ≤ 10 times of normal value/> 10 times of normal value)57/24
Primary lesion
Depth of invasion (up to subserosa/more)57/24
Lymphnodemetastasi (no/yes)39/42
Hepatic metastasis
Number (single/multiple)45/36
Maximum diameter ( ≤ 5 cm/> 5 cm)59/22
Lobe involved (unilobar/bilobar)64/17
Table 2 Regression statistics for the stepwise cox proportional hazard model1
VariableParameterPHazard Ratio (95% CI)
Diameter > 5 cm1.356570.00133.883 (1.703-8.852)
Extrahep. Met (+).1.194300.01333.301 (1.282-8.502)
Number ≥ 20.854120.02652.349 (1.105-4.997)
D.F.interval < 1 yr0.678380.16021.971 (0.765-5.080)
n (+) of primary0.600340.13521.823 (0.829-4.007)
≥ se (+) of primary0.548770.16761.731 (0.794-3.774)
Table 3 Our proposal staging system for colorectal liver metastases
Staging system
H-factor;
H1: Solitary&Diameter ≤ 5 cm
H2: Solitary&Diameter > 5 cm/Multiple&Diameter ≤ 5 cm
H3: Multiple&Diameter > 5 cm
M-factor;
M0: Extrahepatic metastasis (-)
M1: Extrahepatic metastasis (+): resectable
Staging;
I: H1&M0
II: H2&M0/H1&M1
III: H3&M0/H2&M1
IV: H3&M1
[IVb: any H & unresectable extraheptic metastasis (+)]